Measuring Factor XIII Inhibitors in Patients with Factor XIII Deficiency: A Case Report and Systematic Review of Current Practices in Japan

• Published in: Journal of clinical medicine Vol. 11; no. 6; p. 1699
• Main Authors: Amano, Shiho, Oka, Kohei, Sato, Yutaka, Sano, Chiaki, Ohta, Ryuichi
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 18.03.2022; MDPI
• Subjects: acquired factor XIII deficiency; Antibodies; Antigens; Asymptomatic; bleeding disorder; Case reports; Congenital diseases; factor XIII deficiency; factor XIII inhibitors; Hemorrhage; Immunology; Laboratories; Mutation; Patients; Plasma; Review; Surgery; Systematic review; Japan; factor XIII deficiency; acquired factor XIII deficiency; bleeding disorder; factor XIII inhibitors
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm11061699

Factor XIII (FXIII) deficiency is a rare but serious coagulopathy. FXIII is critical in blood coagulation, and FXIII deficiencies can lead to uncontrolled or spontaneous bleeding. FXIII deficiencies can be congenital or acquired; acquired FXIII deficiency can be categorized as autoimmune and non-autoimmune. Immunological tests to measure FXIII inhibitors are required to diagnose acquired FXIII deficiency; however, appropriate test facilities are limited, which increases the turnaround time of these tests. In the case of critical bleeding, delayed test results may worsen prognosis due to delayed treatment. Here, we report a case of acquired FXIII deficiency, followed by a review of FXIII deficiency cases in Japan. We performed a systematic review to investigate the present conditions of the diagnosis and treatment of FXIII deficiency, including the measurement of FXIII inhibitors in Japan. FXIII inhibitor testing was only performed in 29.7 of acquired FXIII deficiency cases. Clinical departments other than internal medicine and pediatrics were often involved in medical treatment at the time of onset. Therefore, it is important for doctors in clinical departments other than internal medicine and pediatrics to consider FXIII deficiency and perform FXIII inhibitor testing when examining patients with prolonged bleeding of unknown cause or persistent bleeding after trauma.